Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): Results from a randomised, phase 3 trial

Yohann Loriot, Kurt Miller, Cora N. Sternberg, Karim Fizazi, Johann S. De Bono, Simon Chowdhury, Celestia S. Higano, Sarah Noonberg, Stefan Holmstrom, Harry Mansbach, Frank G. Perabo, De Phung, Cristina Ivanescu, Konstantina Skaltsa, Tomasz M. Beer, Bertrand Tombal

Research output: Contribution to journalArticlepeer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): Results from a randomised, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences